Exact Therapeutics AS
Research Exact Therapeutics AS (EXTX) on Bullrun: market cap NOK 50.61M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEXTX
- ExchangeOL
- CountryNorway
- SectorHealthcare
- IndustryBiotechnology
- CurrencyNOK
- Market capNOK 50.61M
- Financial periodFY2025
- Net income-NOK 86.97M
- Free cash flow-NOK 72.31M
Valuation Snapshot
latest market cap is NOK 50.61M.
About Exact Therapeutics AS
EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a novel ultrasound-mediated technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT) in Norway. The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various applications, including oncology, neurological conditions, and gene therapy.
Frequently asked questions
What is Exact Therapeutics AS's market cap?
Exact Therapeutics AS's market capitalization is NOK 50.61M.
What does Exact Therapeutics AS do?
EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a novel ultrasound-mediated technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT) in Norway.